Texas § 169.006 ADMINISTRATION OF LOW-THC CANNABIS BY PULMONARY INHALATION.

Texas Statutes

§ 169.006 — ADMINISTRATION OF LOW-THC CANNABIS BY PULMONARY INHALATION.

Texas § 169.006

Code OCOccupations Code

This text of Texas § 169.006 (ADMINISTRATION OF LOW-THC CANNABIS BY PULMONARY INHALATION.) is published on Counsel Stack Legal Research, covering Texas primary law. Counsel Stack provides free access to over 12 million legal documents including statutes, case law, regulations, and constitutions.

Bluebook

Tex. Occupations Code Code Ann. § 169.006 (2026).

Text

Sec. 169.006. ADMINISTRATION OF LOW-THC CANNABIS BY PULMONARY INHALATION.

(a)A physician may prescribe pulmonary inhalation of an aerosol or vapor as a means of administration of low-THC cannabis if the physician determines that based on the patient's condition there is a medical necessity for that means of administration.

(b)The prescription under Subsection (a) must specify the amount of tetrahydrocannabinols in each dosage unit to be administered by pulmonary inhalation that is medically necessary based on the patient's condition.

(c)The executive commissioner shall adopt rules:

(1)related to medical devices for pulmonary inhalation of low-THC cannabis; and

(2)establishing a reasonable timeline for reviewing and granting approval for medical devices for pulmonary inhalation.

Free access — add to your briefcase to read the full text and ask questions with AI

Sec. 169.006. ADMINISTRATION OF LOW-THC CANNABIS BY PULMONARY INHALATION. (a) A physician may prescribe pulmonary inhalation of an aerosol or vapor as a means of administration of low-THC cannabis if the physician determines that based on the patient's condition there is a medical necessity for that means of administration.
(b) The prescription under Subsection (a) must specify the amount of tetrahydrocannabinols in each dosage unit to be administered by pulmonary inhalation that is medically necessary based on the patient's condition.
(c) The executive commissioner shall adopt rules:
(1) related to medical devices for pulmonary inhalation of low-THC cannabis; and
(2) establishing a reasonable timeline for reviewing and granting approval for medical devices for pulmonary inhalation.